This document discusses rodent tumors that are of questionable relevance to human cancer risk. It notes several types of tumors seen in rodents that are due to species-specific modes of action not relevant to humans, such as renal tumors from α-2u-globulin nephropathy in male rats or mesothelial tumors from β2 receptor agonists in rats. It also lists tumors found in unique rodent tissues like the Harderian gland that are absent in humans. Many of these rodent-specific tumors found in 2-year cancer studies were associated with genotoxic chemicals or irritants and are not predictive of human cancer risk.
CANCER: A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSISCharu Pundir
It is a basic review presentation on cancer, world's second most dreadful disease followed by cardiovascular events, involving basic defination, pathophysiology, screening methods, types of tumor, tumor origin, cancer cell lines, treatment, recent advancements made in the field and diagnosis.
CANCER: A REVIEW: WORLD'S SECOND MOST FEARED DIAGNOSISCharu Pundir
It is a basic review presentation on cancer, world's second most dreadful disease followed by cardiovascular events, involving basic defination, pathophysiology, screening methods, types of tumor, tumor origin, cancer cell lines, treatment, recent advancements made in the field and diagnosis.
Cancer is disease where cells grows out of control and invade, erode and destroy normal tissues
Normal body cells grow, divide and die in orderly fashion
Cancer cell does not obey this path
Cancer cells don't die (Immortality). They just continue to grow and divide in disorderly fashion
This makes it hard for the body to work the way it should
Anti-Neoplastic agents(Anti-cancer drugs)-History-Mechanism of actions-Classifications,SAR,Synthesis and Uses.(Medicinal chemistry)
P.Ravisankar
Vignan Pharmacy College
Vadlamudi. Guntur-A.P. India.
2D CAT Based Modeling of Tumour Growth and Drug TransportEditor IJMTER
The transition of normal cells in the tissue that leads into tumour and spreads throughout
depending upon its behavioural conditions is a complex biological process studied through the use of
both in vivo and in vitro experimentation. Mathematical models provide the approach by using a
controlled environment in which a system can be described quantitatively. This can also yield data
which predicts the behaviour of cells and likely medical conditions after thorough analysis by the
modeller. In an effort to study the characteristics that increase cell fitness, the paper presents a 2D
Cellular Automaton model that uses computer simulation to describe the invasion of healthy tissue
by cancer cells. The growth process is simulated and it was found that movement of cells affects
tumour growth rate. It was also found that the relative distance of the tumour initiation area from
neighbouring vessels influences the growth of tumour. The model and the simulation software
developed thus can be used to understand the dynamics of early tumour growth and to explore
various hypotheses of tumour growth relevant to drug delivery in chemotherapy. Importantly, this
approach highlights that vessel displacement should not be neglected in tumour growth models. The
paper thus presents two models i.e cancer growth model and drug transport model for tumour growth
and treatment that will help to diagnose the early tumour growth. Though cancer is uncurable;early
and quick detection of cancer will help doctors in better way by suggesting quick remedial action
against it.
In the recent years, knowledge about cancer biomarkers has increased tremendously
providing great opportunities for improving the management of cancer patients by
enhancing the efficiency of detection and efficacy of treatment.
• Recent technological advancement has enabled the examination of many
potential biomarkers and renewed interest in developing new biomarkers.
• Biomarkers of cancer could include a broad range of biochemical entities, such as nucleic
acids, proteins, sugars, lipids, and small metabolites, cytogenetic and cytokinetic
parameters as well as whole tumour cells found in the body
fluid. A COMPREHENSIVE UNDERSTANDING OF THE RELEVANCE
OF EACH BIOMARKER WILL BE VERY IMPORTANT NOT
ONLY FOR DIAGNOSING THE DISEASE RELIABLY, BUT ALSO
HELP IN THE CHOICE OF MULTIPLE THERAPEUTIC
ALTERNATIVES CURRENTLY AVAILABLE THAT IS LIKELY TO
BENEFIT THE PATIENTS.• Measure or evaluate the normal biological process, pathogenic processes, or
pharmacological response to a therapeutic interventions.
• Includes ~ diagnostic test and imaging technology
• “ Cancer is clusters disease involving alterations in status and expression of
multiple genes that confer a survival advantage & diminished proliferative
potential to somatic or germinal cells"
Specific to tumor
• Level change in response to tumor size
• No fluctuations in level
• Low level in healthy individual
• Predict recurrence
• Test should be cost effective
DNA methylation
2. Alteration pattern of histone modification
3. Alterations in chromatin condensation
Carcinogenesis refers to the process by which a normal cell is transformed into a malignant cell and repeatedly divides to become a cancer
Chemicals which initiate this process is called chemical carcinogens
Chemicals which increase the effectiveness of carcinogens is called co-carcinogens
REGULATORY BACKGROUND
ROLE OF PROTO-ONCOGENES AND TUMOR SUPPRESSOR GENES
ACTIVATION OF PROTO ONCOGENES
OXIDATIVE STRESS IN CARCINOGENESIS
OECD guidelines
451- Carcinogenecity studies
453- Combined chronic toxicity/carcinogenecity
ICH guidelines
S1A- Guideline on the need for carcinogenicity studies of
pharmaceuticals
S1B- Testing for carcinogenicity of pharmaceuticals
S1C- Dose selection for carcinogenicity studies of pharmaceuticals
Cancer is disease where cells grows out of control and invade, erode and destroy normal tissues
Normal body cells grow, divide and die in orderly fashion
Cancer cell does not obey this path
Cancer cells don't die (Immortality). They just continue to grow and divide in disorderly fashion
This makes it hard for the body to work the way it should
Anti-Neoplastic agents(Anti-cancer drugs)-History-Mechanism of actions-Classifications,SAR,Synthesis and Uses.(Medicinal chemistry)
P.Ravisankar
Vignan Pharmacy College
Vadlamudi. Guntur-A.P. India.
2D CAT Based Modeling of Tumour Growth and Drug TransportEditor IJMTER
The transition of normal cells in the tissue that leads into tumour and spreads throughout
depending upon its behavioural conditions is a complex biological process studied through the use of
both in vivo and in vitro experimentation. Mathematical models provide the approach by using a
controlled environment in which a system can be described quantitatively. This can also yield data
which predicts the behaviour of cells and likely medical conditions after thorough analysis by the
modeller. In an effort to study the characteristics that increase cell fitness, the paper presents a 2D
Cellular Automaton model that uses computer simulation to describe the invasion of healthy tissue
by cancer cells. The growth process is simulated and it was found that movement of cells affects
tumour growth rate. It was also found that the relative distance of the tumour initiation area from
neighbouring vessels influences the growth of tumour. The model and the simulation software
developed thus can be used to understand the dynamics of early tumour growth and to explore
various hypotheses of tumour growth relevant to drug delivery in chemotherapy. Importantly, this
approach highlights that vessel displacement should not be neglected in tumour growth models. The
paper thus presents two models i.e cancer growth model and drug transport model for tumour growth
and treatment that will help to diagnose the early tumour growth. Though cancer is uncurable;early
and quick detection of cancer will help doctors in better way by suggesting quick remedial action
against it.
In the recent years, knowledge about cancer biomarkers has increased tremendously
providing great opportunities for improving the management of cancer patients by
enhancing the efficiency of detection and efficacy of treatment.
• Recent technological advancement has enabled the examination of many
potential biomarkers and renewed interest in developing new biomarkers.
• Biomarkers of cancer could include a broad range of biochemical entities, such as nucleic
acids, proteins, sugars, lipids, and small metabolites, cytogenetic and cytokinetic
parameters as well as whole tumour cells found in the body
fluid. A COMPREHENSIVE UNDERSTANDING OF THE RELEVANCE
OF EACH BIOMARKER WILL BE VERY IMPORTANT NOT
ONLY FOR DIAGNOSING THE DISEASE RELIABLY, BUT ALSO
HELP IN THE CHOICE OF MULTIPLE THERAPEUTIC
ALTERNATIVES CURRENTLY AVAILABLE THAT IS LIKELY TO
BENEFIT THE PATIENTS.• Measure or evaluate the normal biological process, pathogenic processes, or
pharmacological response to a therapeutic interventions.
• Includes ~ diagnostic test and imaging technology
• “ Cancer is clusters disease involving alterations in status and expression of
multiple genes that confer a survival advantage & diminished proliferative
potential to somatic or germinal cells"
Specific to tumor
• Level change in response to tumor size
• No fluctuations in level
• Low level in healthy individual
• Predict recurrence
• Test should be cost effective
DNA methylation
2. Alteration pattern of histone modification
3. Alterations in chromatin condensation
Carcinogenesis refers to the process by which a normal cell is transformed into a malignant cell and repeatedly divides to become a cancer
Chemicals which initiate this process is called chemical carcinogens
Chemicals which increase the effectiveness of carcinogens is called co-carcinogens
REGULATORY BACKGROUND
ROLE OF PROTO-ONCOGENES AND TUMOR SUPPRESSOR GENES
ACTIVATION OF PROTO ONCOGENES
OXIDATIVE STRESS IN CARCINOGENESIS
OECD guidelines
451- Carcinogenecity studies
453- Combined chronic toxicity/carcinogenecity
ICH guidelines
S1A- Guideline on the need for carcinogenicity studies of
pharmaceuticals
S1B- Testing for carcinogenicity of pharmaceuticals
S1C- Dose selection for carcinogenicity studies of pharmaceuticals
A transgenic animal is one that carries a foreign gene that has been deliberately inserted into its genome.
Transgenesis is the process by which mixing up of genes takes place.
Foreign genes are inserted into the germ line of the animal, so it can be transmitted to the progeny.
Transgenic technology has led to the development of fishes, live stock and other animals with altered genetic profiles which are useful to mankind.
First transgenic animal was a ‘Supermouse’ created by Ralph Brinster (U Pennsylvania) and Richard Palmiter (University of Washington) in 1982.
It was created by inserting a human growth hormone gene in mouse genome.
The offspring was much larger than the parents.
Mouse – common transgenic expt.
Other animals include pig, goat, cow, sheep, fish etc.
TOXICOLOGY STUDY IS VERY ESSENTIAL FOR DRUG DISCOVERY. INTERNATIONAL COUNCIL FOR HARMONIZATION (ICH) HAS IMPLEMENTED SOME BASIC RULES AND REGULATION REGARDING THE TOXICITY STUDY ON ANIMAL DURING PRE-CLINICAL TRIAL, WHICH IS A PART OF DRUG DISCOVERY PROCESS. HERE SOME OF THE BASIC TEST ARE DISCUSSED ALONG WITH SOME BASIC CONCEPTS OF GENETICS. HOPE THIS WILL HELP THE STUDENTS TO UNDERSTAND THE TOPIC.
Similar to Rodent tumors of questionable relevance to man (20)
Adverse, Non-adverse and Adaptive Responses in Toxicologic Pathology - JSTPJeremy Maronpot
Discussion of definitions of adversity followed by defining NOAELs using practical case examples of adverse, non-adverse and adaptive responses along with how to deal with lesion reversibility and exacerbation of background lesions in preclinical toxicology studies. Includes comments on justifying results to regulatory authorities.
Adverse, Non-adverse and Adaptive Responses in Toxicologic Pathology-JSTPJeremy Maronpot
Discussion of definitions of adversity followed by defining NOAELs using practical case examples of adverse, non-adverse and adaptive responses along with how to deal with lesion reversibility and exacerbation of background lesions in preclinical toxicology studies. Includes comments on justifying results to regulatory authorities.
Adverse, Non-adverse and Adaptive Responses in Toxicologic Pathology - JSTPJeremy Maronpot
Discussion of definitions of adversity followed by defining NOAELs using practical case examples of adverse, non-adverse and adaptive responses along with how to deal with lesion reversibility and exacerbation of background lesions in preclinical toxicology studies. Includes comments on justifying results to regulatory authorities.
http://focusontoxpath.com/adverse-responses/
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
Richard's aventures in two entangled wonderlandsRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...University of Maribor
Slides from:
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Track: Artificial Intelligence
https://www.etran.rs/2024/en/home-english/
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
1. Xenobiotic-induced Rodent
Tumors of Questionable
Relevance to Human Cancer Risk
R. R. Maronpot
Maronpot@me.com
Photomicrographs courtesy of the National Toxicology Program (http://ntp.niehs.nih.gov)
2. Rodent Tumors of Questionable
Relevance
Rodent-Specific Mode of Action
• Renal tumors secondary to α-2u-
globulin nephropathy
• Urinary bladder tumors
secondary to irritation
• Mesovarian leiomyomas
secondary to β2 receptor agonists
• Carcinoids secondary to H2
antagonists
• Thyroid follicular tumors
• Uterine endometrial carcinoma
secondary to dopamine agonists
• Leydig cell tumors in rats
secondary to hormonal
perturbations
Tumors in Unique Rodent Tissues
• Harderian Gland
• Preputial Gland
• Clitoral Gland
• Zymbal’s Gland
• Forestomach
3. Α-2u globulin nephropathy
Proposed key events
Chemical exposure and binding to α-2u globulin
Accumulation of the bound α-2u in renal tubular
epithelial cells
Cytotoxicity to renal tubular epithelial cells
Compensatory renal tubular cell proliferation
Development of renal tumors
6. Α-2u globulin nephropathy
• Animals affected
– Mature male rat under influence of testosterone produces
large amount of α-2u globulin
• Xenobiotics associated with α-2u globulin nephropathy
– JP-4 & other jet fuels hexachloroethane
– Isophorone d-limonene
– Parachlorobenzene Pentachloroethane
– Unleaded gasoline Nitrotoluene
• Unaffected mammals
– Female rats Male and female mice Humans
– Male NCI-Black-Reiter rat
7. Urinary Bladder Tumors
• Secondary to irritation
– Mechanical irritation from foreign bodies or
calculi
• Affects rats and mice
– Threshold effect – only seen at doses of chemical
that produce calculi
• Agents associated with urinary bladder
tumors
– Uracil Cyclamate
– Chronic irritation
9. Mesovarian Leiomyomas in Rats
• Seen following administration of β2-receptor
adrenergic stimulants
– Proliferation of mesovarian smooth muscle
– Propanolol (adrenergic blocker) prevents formation of
this tumor
• Xenobiotics causing this effect
Salbutamol Terbutaline
• Specific to the rat
– Not seen in mice or hamsters
– Not seen in humans with long history of using β2-
stimulants
10. Carcinoids (Neuroendocrine Tumors)
in the Rodent Stomach
• Associated with prolonged blockage of acid secretion
– Seen for powerful and long-lasting H2-receptor antagonists
& proton-pump inhibitors given at high doses
– SK&F93479 Omeprazole Butachlor Methyleugenol
• Leads to increased gastrin levels
– Stimulation of neuroendocrine cells leading to hyperplasia
and neoplasia
– Slight hypergastrinemia in humans not associated with
hyperplasia or neoplasia of neuroendocrine cells
• Seen at high doses in rodents
– Humans have low serum gastrin levels (margin of safety)
12. Thyroid Follicular Cell Neoplasms
• Caused by altered feedback mechanism resulting in
prolonged stimulation of the thyroid by TSH
• Rats vs. humans lack high-affinity thyroxin-binding globulin,
are more sensitive to inhibition of thyroid peroxidase, are
more sensitive to hepatic enzyme induction
• Categories of altered feedback mechanism
– Interference with iodine uptake & thyroid hormone synthesis or
secretion
• sulfonamides
– Interference with metabolism of T4 or T3
• FD&C Red No. 3 (erythrosine)
– Increased metabolism & excretion of thyroid hormones
• Phenobarbital Polychlorinated biphenyls
14. Uterine Endometrial Carcinomas in
Rats
• Seen in older rats associated with estrogen
dominance
• Permanent estrus and endometrial
stimulation
– Leads to endometrial carcinoma
• Seen in rats treated with dopamine agonists
– Bromocriptine
• Similar endocrine imbalance does not occur in
women
16. Leydig Cell Tumors in Rats
• Interference with Leydig cell control mechanisms
(7 different types of interference)
• All involve the hypothalamic-pituitary-testis axis
• Xenobiotics associated with rat Leydig cell tumors
– Cimetidine Finasteride Flutamide
– Gembibrozil Indomethacin DEHP
• Rats vs humans
– Rats have 14 times more LH receptors
– LHRH receptors unique to the rat
19. Rodent Tumors of Questionable
Relevance
Rodent-Specific Mode of Action
• Renal tumors secondary to α-2u-
globulin nephropathy
• Urinary bladder tumors
secondary to irritation
• Mesovarian leiomyomas
secondary to β2 receptor agonists
• Carcinoids secondary to H2
antagonists
• Thyroid follicular tumors
• Uterine endometrial carcinoma
secondary to dopamine agonists
• Leydig cell tumors in rats
secondary to hormonal
perturbations
Tumors in Unique Rodent Tissues
• Harderian Gland
• Preputial Gland
• Clitoral Gland
• Zymbal’s Gland
• Forestomach
20. 2-Year Oncogenicity Studies Evaluated
Pesticide database
(www.epa.gov/ncct/toxrefdb/)
257 Rat
246 Mouse
281 Total Rodent
1006 Sex/Species
National Toxicology Program database
(http://ntp.niehs.nih.gov/)
552 Total Rodent
~2200 Sex/Species
21. Pesticide Database
One study (1 of 281) has an increased incidence of
Harderian gland tumors in female mice and
forestomach tumors in male and female mice.
No other sex/species exposure groups in the 280
other 2-year oncogenicity studies had increased
incidences of these rodent only tumors.
22. NTP database
90 of the 552 studies available for review had
increased incidence of at least one of the list
of 5 rodent unique tissue tumors in at least
one sex/species.
23. NTP Database
Forestomach
Female rat 20; Male rat 24; Female mouse 34; Male mouse 29
Zymbal’s gland
Female rat 19; Male rat 22; Female mouse 4; Male mouse 3
Harderian gland
Male rat 1; Female mouse 15; Male mouse 16
Preputial gland Clitoral gland
Male rat 13; Male mouse 5 Female rat 16
24. NTP Database
In 11 cases there was an increased incidence of a single
rodent specific tumor in a single sex/species as the only
positive neoplastic finding.
Female rat: Clitoral gland 2; Zymbal’s gland 1
Male rat: Forestomach 1; Preputial gland 1
Female mouse: Forestomach 4
Male mouse: Forestomach 1
(90/552 positive studies)
25. Harderian gland
Described by Johann Jacob Harder in 1694
Present in terrestrial vertebrates – amphibians to
mammals
In mammals – not present in cattle, horses, carnivores,
higher primates including humans
Functional activities include (depending on species) –
lubrication, immune response, pheromone production,
saliva, osmoregulation, photoreception,
thermoregulation, elaboration of growth factors.
Has been shown to possess metabolic capability
– Cytochrome P450, lipid metabolism,
and porphyrin metabolism
26. Female mice
15 positive studies
In one case the only tumor in study.
9/15 involved genotoxic xenobiotics including the study with only
positive tumor site
Male mice
16 positive studies
In one case the only tumor in study
9/16 involved genotoxic xenobiotics including the study with only
positive tumor site
In the only tumor site cases in mice, both sexes had Harderian gland
tumors.
Male rat
Single study with Harderian gland tumor, multi-site genotoxic
carcinogen.
Harderian Gland Tumor
28. Effect of Diet on Spontaneous
Harderian Gland Tumors
NIH-07
overall
incidence
NIH-2000
overall
incidence
Female
mouse
129/3286
3.9%
183/1448
12.6%
Male
mouse
175/3286
5.3%
223/1399
15.9%
Male
rat
1/3245
0.03%
1/1399
0.07%
29. Harderian Gland
• Multifunctional gland
• Metabolically active
• Spontaneous incidence influenced by diet
• Tumors typically seen in studies where other
tumors are associated with treatment
• Humans do not have Harderian glands
31. Preputial Gland Tumors in NTP Studies
Male mice
5 positive studies
All are multisite carcinogens
4/5 are genotoxic
3/5 also had Zymbal’s gland tumors
4/5 had skin and/or Zymbal’s gland tumors
Male rat
13 positive studies
2 studies the only tumor in male rat, 1 case only tumor in study
5/13 are genotoxic
5/11 also had Zymbal’s gland tumors
4/11 had skin tumors
5/11 had skin and/or Zymbal’s gland tumors
32. Female rat
16 positive studies in NTP database
11/16 were genotoxic
4 studies only tumor in female rat,
2 cases only tumor in study
9/12 also had Zymbal’s gland tumors
5/12 also had skin tumors
10/12 had skin and/or Zymbal’s gland tumors
2/4 were positive in male rat preputial gland
Clitoral Gland Tumors in NTP Studies
34. Preputial and Clitoral Glands
• Specialized sebaceous glands
• Typically associated with other cutaneous tumors
• In 7 studies both rat preputial (7/13) and clitoral
(7/16) gland tumors were present.
• Spontaneous tumor rates not affected by diet.
• Not present in humans.
35. Zymbal’s gland
Modified sebaceous glands along the base of the ear.
Possess cytochrome P450 metabolizing enzymes.
May be deficient in some phase II metabolizing enzymes
http://www.item.fraunhofer.de/reni
37. Zymbal’s Gland Tumors
NTP Mouse Studies
Female mouse
4 positive studies all multisite carcinogens
2/4 were genotoxic carcinogens
Male mouse
3 positive studies all multisite carcinogens
All positive for preputial gland
2/3 were genotoxic carcinogens
38. Zymbal’s Gland Tumors
NTP Rat Studies
Female rat
19 studies positive
14/19 were genotoxic carcinogens
3 were the only female rat tumor in study
6/16 also had skin tumors
9/16 also had clitoral gland tumors
10/16 had clitoral gland and/or skin tumors
Male rat
22 studies positive
16/22 were genotoxic carcinogens
2 were the only male rat tumor in study
16/20 also had skin tumors
5/16 also had preputial gland tumors
16/16 had preputial gland and/or skin tumors
40. Incidence of Zymbal’s gland tumors in Control Rodents
Fed NIH-07 Diet
NTP database
Derm
acetone
Derm
ethanol
Derm Gavage
corn oil
Gavage
methyl
cellulose
Gavage
water
Inhalation Feed Water Total and
%
Female
Rat
1/100 2/301 0/51 1/401 0/100 0/50 6/1052 6/1001 5/330 21/3386
0.6%
Male
Rat
1/100 4/302 0/50 2/402 1/101 0/50 15/1055 10/1004 6/331 39/3395
1.2%
Female
Mouse
0/150 0/302 nd 26/463
5.6%
0/100 0/51 1/1077 0/953 0/340 26/3436
0.7%
Male
Mouse
0/150 0/299 nd 23/464
5.0%
0/100 0/50 0/1074 0/952 0/340 24/3429
0.7%
41. Incidence of Zymbal’s gland tumors in Control Rodents
Fed NIH-2000 Diet
NTP database
Derm
ethanol
Gavage
corn oil
Gavage
methyl
cellulose
Gavage
water
Inhalation Feed Water Total and
%
Female
Rat
0/150 1/150 0/100 0/150 4/350 1/250 2/200 8/1350
Male
Rat
1/150 2/150 0/100 0/150 2/349 4/300 2/200 11/1399
Female
Mouse
0/150 0/148 0/100 0/150 0/400 1/300 0/200 1/1448
Male
Mouse
0/150 0/150 0/100 0/150 0/400 0/250 0/199 0/1399
FM
5.6%
MM
5.0%
42. Zymbal’s Gland Tumors
• Modified sebaceous gland
• Typically associated with other cutaneous tumors
• Metabolically active site
• Majority associated with genotoxic carcinogens
• Decreased diet-related spontaneous tumor rates in
mice
44. Forestomach Tumors in NTP Mouse Studies
Female mouse
35 studies positive (from 90/552 studies)
22/35 genetox positive
17/35 irritants
28/35 genotoxic or irritant
16 only female mouse tumor
13/16 genetox positive or irritant
Male mouse
30 studies positive
20/30 genetox positive
16/30 irritants
25/30 genotoxic or irritant
8 only male mouse tumor
8/8 genetox positive or irritant
45. Female rat
20 studies positive (from 90/552 studies)
15/20 genetox positive
10/20 irritants
16/20 genotoxic and/or irritant
9 only female rat tumor
8/9 genotoxic or irritant
Male rat
24 studies positive
18/24 genetox positive
11/24 irritants
21/24 genotoxic and/or irritant
9 only male rat tumor
8/9 genotoxic or irritant
Forestomach Tumors in NTP Rat Studies
46. Forestomach Tumors by Route of Administration
Female mouse
21/35 Gavage studies
18/21 corn oil
3/21 water
7/35 Feed
Male mouse
19/30 Gavage studies
15/19 corn oil
3/19 water
1/19 methyl cellulose
5/30 Feed
Female rat
15/20 Gavage studies
10/15 corn oil
4/15 water
1/15 methyl cellulose
4/20 Feed
Male rat
15/24 Gavage studies
11/15 corn oil
4/15 water
8/24 Feed
47. Incidence of Forestomach tumors in Control Rodents
Fed NIH-07 Diet
NTP database
Derm
acetone
Derm
ethanol
Derm Gavage
corn oil
Gavage
methyl
cellulose
Gavage
water
Inhalation Feed Water Total and
%
Female
Rat
0/100 0/301 0/51 2/401 0/100 0/50 1/1052 2/1001 1/330 6/3386
0.2%
Male
Rat
1/100 0/302 2/50 2/402 0/101 0/50 1/1055 0/1004 0/331 6/3395
0.2%
Female
Mouse
2/150
1.3%
2/299
0.6%
nd 19/463
4.1%
1/100
1.0%
0/51
0%
10/1077
0.9%
16/953
1.7%
5/340
1.5%
55/3433
1.6%
Male
Mouse
2/150
1.3%
6/302
2.0%
nd 22/464
4.7%
0/100
0%
0/50
0%
7/1074
0.7%
14/952
1.5%
4/340
1.2%
55/3432
1.6%
48. Incidence of Forestomach tumors in Control Rodents
Fed 2000 Diet
NTP database
Derm
ethanol
Gavage
corn oil
Gavage
methyl
cellulose
Gavage
water
Inhalation Feed Water Total and
%
Female
Rat
0/150 1/150 1/100 1/150 0/350 1/250 1/200 5/1350
0.4%
Male
Rat
2/150 0/150 0/100 0/150 0/349 0/300 1/200 3/1399
0.2%
Female
Mouse
3/150
2.0%
4/148
2.7%
1/100
1.0%
3/150
2.0%
6/400
1.5%
5/300
1.7%
3/200
1.5%
25/1448
1.7%
Male
Mouse
1/150 1/150
0.7%
2/100 3/150 4/400 4/250 3/199 18/1399
1.3%
FM
4.1%
MM
4.7%
49. Forestomach Tumors
• Susceptible to local combination of chronic wounding (irritation)
and mutagenicity
• More likely to develop from direct exposure; more likely in gavage
studies
• Metabolically active site
• Decreased diet-related spontaneous tumor rate in mice
• In 8/9 and 9/9 cases of only tumor in male or female rats,
respectively, also tumor in opposite sex.
• In 7/8 and 12/16 cases of only tumor in male or female mice,
respectively, also tumor in opposite sex.
50. Site Concordance
Target organ concordance need not be a prerequisite for evaluating the
implications of animal study results for humans.
There is evidence that growth control mechanisms at the level of the cell
are homologous among mammals, but these mechanisms are not
necessarily site concordant.
51. Site Concordance
Target organ concordance need not be a prerequisite for evaluating the
implications of animal study results for humans.
There is evidence that growth control mechanisms at the level of the cell
are homologous among mammals, but these mechanisms are not
necessarily site concordant.
Tumors in Unique Rodent Tissues
• Harderian Gland
• Preputial Gland
• Clitoral Gland
• Zymbal’s Gland
• Forestomach
Concerns about the significance
of these to human cancer risk
can be addressed using the
mode of action/human relevance
framework approach.
<
52. Rodent Cancer Study Databases
Pesticide database
(www.epa.gov/ncct/toxrefdb/)
National Toxicology Program database
(http://ntp.niehs.nih.gov/)
Editor's Notes
Mallory-Heidenhain stain
Male NCI-Black-Reiter rat lack genes to produce alpha-2u globulin in the liver.
Enterochromaffin cells. Inhibition of acid secretion by parietal cells leads to increased gastrin secretion by G cells in stomach.
Example from methyleugenol. Loss of parietal cells due to mucosal atrophy. Increased gastrin and increased proliferation of neuroendocrine cells.
Methyleugenol, natural constituent. GRAS flavoring agent in a variety of foods. Insect attractant.
Sulfonamides – sensitive species – rat 500 times more sensitive than primates; rat, mouse, dog. Insensitive primates, guinea pig, chicken. FD&C Red No. 3 – no effect in rats unless there was increase in TSH (threshold)
CNS – decreased prolactindownregulation of LH receptore on Leydig cellsdecreased testosterone productioncompensatory increase in circulating LH proliferation of Leygid cells. Agents that block androgen receptors.
90 of 552 studies
MOUSE studies
The 2 only male rat tumors also were the only tumors in female rats